Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
36
SKHHY Quote, Financials, Valuation and Earnings
Last price:
$17.05
Seasonality move
:
-0.38%
Day range:
$16.90 - $17.16
52-week range:
$13.00 - $19.25
Dividend yield:
4.13%
P/E ratio:
23.70x
P/S ratio:
1.25x
P/B ratio:
1.71x
Volume:
56K
Avg. volume:
52.3K
1-year change:
-1.54%
Market cap:
$8.3B
Revenue:
$6.1B
EPS (TTM):
$0.71
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | $11.00 |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | $9.50 |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -- | -- | $18.94 |
|
LVCLF
Algorae Pharmaceuticals Ltd.
|
-- | -- | -- | -- | -- |
|
SPHRY
Starpharma Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
$16.89 | -- | $8.3B | 23.70x | $0.42 | 4.13% | 1.25x |
|
ATHE
Alterity Therapeutics Ltd.
|
$3.44 | $11.00 | $62.4M | -- | $0.00 | 0% | 3.58x |
|
IMMP
Immutep Ltd.
|
$2.80 | $9.50 | $407.6M | -- | $0.00 | 0% | 153.33x |
|
KZIA
Kazia Therapeutics Ltd.
|
$8.45 | $18.94 | $95.8M | -- | $0.00 | 0% | 381.81x |
|
LVCLF
Algorae Pharmaceuticals Ltd.
|
$0.0079 | -- | $13.3M | -- | $0.00 | 0% | 0.14x |
|
SPHRY
Starpharma Holdings Ltd.
|
$3.15 | -- | $131.7M | -- | $0.00 | 0% | 14.62x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
36.93% | 0.161 | -- | 0.84x |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | 2.224 | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | 0.527 | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-6.76% | 4.448 | 5.57% | 0.07x |
|
LVCLF
Algorae Pharmaceuticals Ltd.
|
-- | -3.348 | -- | -- |
|
SPHRY
Starpharma Holdings Ltd.
|
9.65% | 3.556 | -- | 4.93x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKHHY
Sonic Healthcare Ltd.
|
-- | -- | 4.54% | 6.72% | -- | -- |
|
ATHE
Alterity Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
IMMP
Immutep Ltd.
|
-- | -- | -- | -- | -- | -- |
|
KZIA
Kazia Therapeutics Ltd.
|
-- | -- | -784.09% | -1083.16% | -- | -- |
|
LVCLF
Algorae Pharmaceuticals Ltd.
|
-- | -- | -- | -- | -- | -- |
|
SPHRY
Starpharma Holdings Ltd.
|
-- | -- | -40.48% | -43.48% | -- | -- |
Sonic Healthcare Ltd. vs. Competitors
-
Which has Higher Returns SKHHY or ATHE?
Alterity Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Alterity Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B ATHEAlterity Therapeutics Ltd.-- -- -- -
What do Analysts Say About SKHHY or ATHE?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Alterity Therapeutics Ltd. has an analysts' consensus of $11.00 which suggests that it could grow by 219.68%. Given that Alterity Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Alterity Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 ATHEAlterity Therapeutics Ltd.1 0 0 -
Is SKHHY or ATHE More Risky?
Sonic Healthcare Ltd. has a beta of 1.091, which suggesting that the stock is 9.098% more volatile than S&P 500. In comparison Alterity Therapeutics Ltd. has a beta of 0.114, suggesting its less volatile than the S&P 500 by 88.643%.
-
Which is a Better Dividend Stock SKHHY or ATHE?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.13%. Alterity Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Alterity Therapeutics Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or ATHE?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Alterity Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Alterity Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.70x while Alterity Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.25x versus 3.58x for Alterity Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.25x 23.70x -- -- ATHEAlterity Therapeutics Ltd.3.58x -- -- --
-
Which has Higher Returns SKHHY or IMMP?
Immutep Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Immutep Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B IMMPImmutep Ltd.-- -- -- -
What do Analysts Say About SKHHY or IMMP?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Immutep Ltd. has an analysts' consensus of $9.50 which suggests that it could grow by 239.29%. Given that Immutep Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Immutep Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 IMMPImmutep Ltd.1 0 0 -
Is SKHHY or IMMP More Risky?
Sonic Healthcare Ltd. has a beta of 1.091, which suggesting that the stock is 9.098% more volatile than S&P 500. In comparison Immutep Ltd. has a beta of 1.756, suggesting its more volatile than the S&P 500 by 75.579%.
-
Which is a Better Dividend Stock SKHHY or IMMP?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.13%. Immutep Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Immutep Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or IMMP?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Immutep Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Immutep Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.70x while Immutep Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.25x versus 153.33x for Immutep Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.25x 23.70x -- -- IMMPImmutep Ltd.153.33x -- -- --
-
Which has Higher Returns SKHHY or KZIA?
Kazia Therapeutics Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Kazia Therapeutics Ltd.'s return on equity of -1083.16%.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B KZIAKazia Therapeutics Ltd.-- -- -$6.3M -
What do Analysts Say About SKHHY or KZIA?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Kazia Therapeutics Ltd. has an analysts' consensus of $18.94 which suggests that it could grow by 124.09%. Given that Kazia Therapeutics Ltd. has higher upside potential than Sonic Healthcare Ltd., analysts believe Kazia Therapeutics Ltd. is more attractive than Sonic Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 KZIAKazia Therapeutics Ltd.1 0 0 -
Is SKHHY or KZIA More Risky?
Sonic Healthcare Ltd. has a beta of 1.091, which suggesting that the stock is 9.098% more volatile than S&P 500. In comparison Kazia Therapeutics Ltd. has a beta of 1.775, suggesting its more volatile than the S&P 500 by 77.474%.
-
Which is a Better Dividend Stock SKHHY or KZIA?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.13%. Kazia Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Kazia Therapeutics Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or KZIA?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Kazia Therapeutics Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Kazia Therapeutics Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.70x while Kazia Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.25x versus 381.81x for Kazia Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.25x 23.70x -- -- KZIAKazia Therapeutics Ltd.381.81x -- -- --
-
Which has Higher Returns SKHHY or LVCLF?
Algorae Pharmaceuticals Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Algorae Pharmaceuticals Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B LVCLFAlgorae Pharmaceuticals Ltd.-- -- -- -
What do Analysts Say About SKHHY or LVCLF?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Algorae Pharmaceuticals Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sonic Healthcare Ltd. has higher upside potential than Algorae Pharmaceuticals Ltd., analysts believe Sonic Healthcare Ltd. is more attractive than Algorae Pharmaceuticals Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 LVCLFAlgorae Pharmaceuticals Ltd.0 0 0 -
Is SKHHY or LVCLF More Risky?
Sonic Healthcare Ltd. has a beta of 1.091, which suggesting that the stock is 9.098% more volatile than S&P 500. In comparison Algorae Pharmaceuticals Ltd. has a beta of -0.656, suggesting its less volatile than the S&P 500 by 165.606%.
-
Which is a Better Dividend Stock SKHHY or LVCLF?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.13%. Algorae Pharmaceuticals Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Algorae Pharmaceuticals Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or LVCLF?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Algorae Pharmaceuticals Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Algorae Pharmaceuticals Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.70x while Algorae Pharmaceuticals Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.25x versus 0.14x for Algorae Pharmaceuticals Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.25x 23.70x -- -- LVCLFAlgorae Pharmaceuticals Ltd.0.14x -- -- --
-
Which has Higher Returns SKHHY or SPHRY?
Starpharma Holdings Ltd. has a net margin of -- compared to Sonic Healthcare Ltd.'s net margin of --. Sonic Healthcare Ltd.'s return on equity of 6.72% beat Starpharma Holdings Ltd.'s return on equity of -43.48%.
Company Gross Margin Earnings Per Share Invested Capital SKHHYSonic Healthcare Ltd.-- -- $8.2B SPHRYStarpharma Holdings Ltd.-- -- $15.9M -
What do Analysts Say About SKHHY or SPHRY?
Sonic Healthcare Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Starpharma Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sonic Healthcare Ltd. has higher upside potential than Starpharma Holdings Ltd., analysts believe Sonic Healthcare Ltd. is more attractive than Starpharma Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SKHHYSonic Healthcare Ltd.0 0 0 SPHRYStarpharma Holdings Ltd.0 0 0 -
Is SKHHY or SPHRY More Risky?
Sonic Healthcare Ltd. has a beta of 1.091, which suggesting that the stock is 9.098% more volatile than S&P 500. In comparison Starpharma Holdings Ltd. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.401%.
-
Which is a Better Dividend Stock SKHHY or SPHRY?
Sonic Healthcare Ltd. has a quarterly dividend of $0.42 per share corresponding to a yield of 4.13%. Starpharma Holdings Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sonic Healthcare Ltd. pays 89.9% of its earnings as a dividend. Starpharma Holdings Ltd. pays out -- of its earnings as a dividend. Sonic Healthcare Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SKHHY or SPHRY?
Sonic Healthcare Ltd. quarterly revenues are --, which are smaller than Starpharma Holdings Ltd. quarterly revenues of --. Sonic Healthcare Ltd.'s net income of -- is lower than Starpharma Holdings Ltd.'s net income of --. Notably, Sonic Healthcare Ltd.'s price-to-earnings ratio is 23.70x while Starpharma Holdings Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sonic Healthcare Ltd. is 1.25x versus 14.62x for Starpharma Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKHHYSonic Healthcare Ltd.1.25x 23.70x -- -- SPHRYStarpharma Holdings Ltd.14.62x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Feb 28
Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.
Buy
90
BNAI alert for Feb 28
Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.
Buy
72
SEZL alert for Feb 28
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
